2026

ENERBABY Reco18

Entrant

Hainan Leyun Biotechnology Co., Ltd.

Category

Branded Content - Healthcare & Pharma

Client's Name

Hong Kong Leyun Technology Trading Co., Ltd.

Country / Region

China

ENERBABY Reco18 demonstrates remarkable scientific depth and technological originality. Powered by an exclusive patented enzymatic technology, the product successfully overcomes traditional bottlenecks in the extraction of active small-molecule compounds. Its core ingredient, Reco18, is 100% derived from pure, natural plant-based sources such as soybeans, cloves, and Sophora japonica (pagoda tree flower buds).

This patented enzymatic process not only maximizes the retention of the plant molecules' potent bioactivity but also significantly reduces the energy consumption and carbon footprint typically associated with conventional chemical extraction. Such an "Earth-friendly" green supply chain and natural traceability mechanism not only validate its clinical efficacy—backed by rigorous data—but also seamlessly integrate cutting-edge bioengineering with reproductive health. Ultimately, it provides a highly forward-looking and innovative intervention strategy for the global assisted reproductive technology (ART) field.

Functionally, ENERBABY Reco18 transcends the superficial nourishment limitations typical of conventional dietary supplements. As a natural component of follicular fluid, Reco18 demonstrates a precise targeting mechanism: it directly intervenes in and optimizes the structural integrity of ovarian mitochondrial membranes.

By scientifically balancing endocrine hormones, providing deep nourishment to ovarian follicles, and significantly reducing follicular atresia, it systematically elevates oocyte quality at the micro-cellular level. This well-defined, targeted mechanism offers a safe and highly efficacious physiological remodeling solution that perfectly aligns with the body's intrinsic biorhythms. Ultimately, it comprehensively addresses the reproductive challenges faced by women of advanced maternal age (AMA) and those with Diminished Ovarian Reserve (DOR).

Extensive clinical trials have proven Reco18's outstanding effectiveness. For patients with compromised embryo quality, it significantly lowers FSH levels by 17.7% and boosts the number of high-quality embryos by an impressive 113%, comprehensively improving ongoing pregnancy rates for advanced-age IVF patients.

Beyond the numbers, Reco18's design deeply embraces humanism and ergonomics. Housed in high-barrier individual sachets to prevent active ingredient oxidation, the product features a carefully crafted taste profile that greatly reduces palatability and swallowing discomfort for women preparing for pregnancy. Its ultimate on-the-go convenience perfectly matches today's fast-paced, highly mobile lifestyles, successfully striking a perfect balance between "rigorous clinical results" and "compassionate user care."

Credits

Chen Jing
Wu Duanyue
Website
2026
Congenital Abnormalities of the Kidneys and Urinary Tract (CAKUT), Healthcare Awards Winner

Entrant

American Kidney Fund

Category

Website - Educational / Training

Country / Region

United States

Branded Content
2026
Dolphin Ka, Healthcare Awards Winner

Entrant

Dolphin Ka

Category

Branded Content - Health Food & Beverage

Country / Region

China

Product Design
2026
Phosphatidylserine Flavored Beverage(Lemon Flavor), Healthcare Awards Winner

Entrant

Germany Batiyus Health Food Limited

Category

Product Design - Design for Society

Country / Region

Hong Kong SAR

Integrated Marketing
2026
Beacon Brand That’s Where We Shine Campaign, Healthcare Awards Winner

Entrant

Core Creative

Category

Integrated Marketing - Integrated Marketing Campaign

Country / Region

United States